How to Take an Indian Herbal Brand to the US & UAE

Educational overview, not legal or regulatory advice: import, labelling and claims rules differ by product and change often — work with qualified regulatory counsel in each destination market.

Why the US and UAE first?

Because both markets pull rather than wait to be pushed. The US is the world’s largest herbal-supplement market, with ingredients India grows — ashwagandha above all — already mainstream: the awareness wave documented in the ashwagandha white-space piece was substantially built on Indian-developed extracts, and the Indian-American diaspora is large, affluent and already convinced. The UAE concentrates a huge Indian expatriate population inside a compact, logistics-friendly, e-commerce-mature market a three-hour flight from home — a rehearsal stage for international operations at manageable scale. Both reward the same asset: a brand story rooted in genuine Indian provenance, which is the one thing local competitors cannot copy.

What changes about your product before marketing starts?

In the US, supplements sell under DSHEA — a food-side regime, not pre-approval — but its obligations are real: FDA facility registration, cGMP-compliant manufacturing, US-format labels, and a claims system of its own in which structure-function statements are permitted with the mandatory FDA disclaimer while disease claims remain prohibited. Note the trap running both directions: US structure-function vocabulary is not legal in India, and Indian ad copy is not compliant in the US — the claims library concept from the FSSAI claims guide must be rebuilt per market, not translated. One more US-specific reality, best faced head-on: regulators and academic studies have historically flagged heavy-metal and quality issues in some imported traditional products, so third-party testing with published certificates is not a differentiator there — it is the entry ticket. In the UAE, the model is registration-gated: health supplements are registered with the relevant authorities before sale, labelling carries Arabic requirements, and halal expectations shape both formulation choices and trust. In both markets, the paperwork is the marketing — every certificate becomes a conversion asset for a buyer trained to be suspicious of unverified imports.

Which entry route fits which stage?

• 1. Marketplace-first (the default). Amazon US, and Amazon.ae plus noon in the Gulf, price the market’s demand with the least capital: fulfilment infrastructure exists, and reviews build the local trust layer. The operational depth required is exactly the marketplace muscle from the Amazon agency-vs-DIY guide, in a foreign jurisdiction.
• 2. Cross-border D2C. Shipping internationally from India works for high-margin, light SKUs and validation phases; duties, delivery times and returns friction cap it as a scale model.
• 3. Local 3PL D2C. Inventory in a US or UAE warehouse behind a localised store — the unit economics unlock, in exchange for working capital and compliance depth.
• 4. Distribution and retail. Ethnic groceries and pharmacy chains move volume and build legitimacy, at the cost of margin and customer-data blindness; usually a layer after digital proof, not before.

The honest sequence for most brands: marketplace validation, then local 3PL D2C once velocity justifies inventory, with distribution layered on top — each stage funded by the previous one’s proof.

How does the marketing differ in each market?

US: discovery is search-and-review-led — Amazon SEO, Google, and the long-form content ecosystem around wellness ingredients. The diaspora is the beachhead audience (cheap to reach, pre-converted, review-generous), but the growth market is the mainstream wellness buyer who knows ashwagandha and has never heard of your brand: for her, credibility is built with testing transparency, clinical-ingredient stories and creator content in the US idiom, not heritage nostalgia. UAE: discovery is Instagram-first and influencer-heavy, commerce splits across marketplaces and COD-friendly D2C, and the calendar matters enormously — Ramadan and the gifting seasons reshape wellness demand in ways an Indian media plan never sees. Arabic-English bilingual creative widens reach beyond the expatriate base. In both markets the compounding move is the same one that works at home: own your branded search early (the moat logic), build replenishment retention to survive acquisition costs (the 45-day playbook travels well), and treat every review as infrastructure.

What kills export attempts?

Four patterns account for most of the graveyard. Unit economics broken by logistics: a ₹499 product with $12 shipping is not a business, and no ad optimises it into one — model landed cost, duties, returns and payment fees per market before the first campaign. Claims vocabulary imported from Indian ads: each regime polices differently, and platforms enforce per-market policies on top. Testing and paperwork treated as later problems: in categories with documented import scrutiny, “later” means delisted or detained. And diaspora complacency: the expatriate beachhead is real but finite — brands that never build the mainstream crossover stall at community scale. The export project, done honestly, is a second company built on the first one’s brand: budget it like one, sequence it like one, and give it the same claims discipline the home market taught you. Category context on our nutrition and wellness page; if the domestic base itself still needs strengthening first, start with the herbal agency shortlist.